Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

BioLineRx, MaRS Innovation Sign Framework Collaboration Agreement
Tuesday, May 17, 2016
Collaboration aims to review innovative projects and assets of startup companies originating from MaRS members, in order to identify in-licensing, co-development or other partnering opportunities.

New Treatment for Pancreatic Cancer
Tuesday, May 17, 2016
Researchers at Purdue University have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis.

Big Data Can Save Lives
Tuesday, May 17, 2016
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.

Triple-Negative Breast Cancer Target Is Found
Tuesday, May 17, 2016
Researchers at UC Berkeley discover a target that drives cancer metabolism in triple-negative breast cancer.

Editas Announces Agreement with Cystic Fibrosis Foundation Therapeutics
Tuesday, May 17, 2016
Editas to receive up to $5 million award to fund genome editing research.

Caribou Biosciences Raises $30M
Tuesday, May 17, 2016
Comapny has announced the completion of a $30 million Series B financing round.

Seres, MSK Announces Agreement
Tuesday, May 17, 2016
Collaboration aims to develop microbiome therapeutics for hematopoietic stem cell transplantation and immuno-oncology treatment.

Advancing the Understanding and Research of Botulinum Neurotoxin Biology
Monday, May 16, 2016
Ipsen and the Institute of Molecular and Cell Biology (IMCB) announce the signature of a research partnership to study the intracellular trafficking of botulinum neurotoxins (BoNTs) within neurons.

FDA Approves Additional Indication for Eisai's Anticancer Agent
Monday, May 16, 2016
Additional indication for in-house developed novel anticancer agent Lenvima (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 4098
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!